Gerd Schnorrenberg

This inventor holds 32 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Boehringer Ingelheim Kg, Boehringer Ingelheim Gmbh, Boehringer Ingelheim Pharma Kg. Active years: 1985-2006.

USPTO Granted Patents = 32 (Patent Applications = 3)

% Patents Active = 96.9

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 6.0

ph-index = 8

Forward Citations = 153(Granted Patents)

Location History:

Ingelheim am Rhein, DE (1985 - 2000)
Biberach/Riss, DE (2000 - 2001)
Biberbach, DE (2003)
Gau-Algesheim, DE (1991 - 2006)

Company Filing History:

20 out of 197

Boehringer Ingelheim Kg

patents

5 out of 306

Boehringer Ingelheim Gmbh

patents

4 out of 149

Boehringer Ingelheim Pharma Kg

patents

4. 1 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

Years Active: 1985-2006

Loading Chart...

Areas of Expertise:

Aryl Glycinamide Derivatives

Neurokinin Antagonists

Amino Acid Derivatives

Pharmaceutical Compositions

Dipeptides

Thieno Pyridines

Pyrrolo[2,3-C]Pyridines

Anti-Hypertensive Agents

Depression Treatment

Manufacturing Processes

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7084140 - Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds (2006-08-01),

2. 6664253 - Neurokinin antagonists (2003-12-16),

3. 6498162 - Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds (2002-12-24),

4. 6413959 - Method of treating depression with arylglycinamide derivatives (2002-07-02),

5. 6303601 - Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds (2001-10-16),

6. 6294556 - Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds (2001-09-25),

7. 6277840 - Neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds (2001-08-21),

8. 6251909 - Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds (2001-06-26),

9. 6235732 - Neurokinin antagonists (2001-05-22),

10. 6232468 - Dipeptides with neurokinin-antagonistic activity (2001-05-15),

11. 6191135 - Neurokinin antagonists (2001-02-20),

12. 6147212 - Amino acid derivatives, processes for the manufacture thereof and (2000-11-14),

13. 6124296 - Arylglycinamide derivatives, methods of producing these substances and (2000-09-26),

14. 6121262 - Arylglycinamide derivatives, processes for the manufacture thereof and (2000-09-19),

15. 6103719 - Neurokinin antagonists, processes for preparing them and pharmaceutical (2000-08-15),

Title: The Innovative Journey of Inventor Gerd Schnorrenberg

Introduction: Gerd Schnorrenberg, a talented inventor hailing from Gau-Algesheim, DE, has left a significant mark in the field of pharmaceuticals with his numerous patents.

Latest Patents: Among his impressive portfolio of 32 patents, one of the latest inventions includes arylglycinamide derivatives. These compounds, along with neurokinin antagonists, have opened new avenues in the realm of pharmaceutical compositions.

Career Highlights: Gerd Schnorrenberg has lent his expertise to renowned companies such as Boehringer Ingelheim KG and Boehringer Ingelheim GmbH, showcasing his innovative capabilities in diverse settings.

Collaborations: Throughout his career, Gerd Schnorrenberg has collaborated with esteemed professionals in the field, including coworkers such as Horst Dollinger and Birgit Jung. This teamwork has further fueled his inventive spirit and led to groundbreaking discoveries.

Conclusion: In conclusion, Gerd Schnorrenberg's journey as an inventor exemplifies dedication, creativity, and a relentless pursuit of innovation. His contributions to the world of pharmaceuticals continue to inspire and make a lasting impact.